Welcome to Gene Therapy
A key title for the exploration of new genetic and stem cell therapy techniques.


Welcome to our new Editor-in-Chief
We are pleased to announce the appointment of Rafael J. Yáñez-Muñoz as the new Editor-in-Chief of Gene Therapy. Dr Yáñez is an expert in the areas of genome editing, gene medicine and stem cells for understanding and progressing treatment of neurodegenerative and inherited diseases, as well as being a leading authority on rare diseases, which affect 6% of people. To read more about Dr Yáñez please see his biography here.

The journal's August issue will be a Special on "Spinraza and advanced therapies: the stakeholder issue". This issue will be a vital resource for all stakeholders in the development of advanced therapies and should not be missed.

We would also like to thank Professor Nicholas Lemoine and Dr Joseph Glorioso for all their hard work as Co-Editors-in-Chief of the journal over the last two decades. They have been instrumental in the journal's success and we are pleased they will still remain with the journal as Editorial Board Members. We wish them all the best for their future endeavours.

Volume 24, No 5
May 2017

ISSN: 0969-7128
EISSN: 1476-5462

2015 Impact Factor 3.242*
111/289 Biochemistry & Molecular Biology
44/161 Biotechnology & Applied Microbiology
60/165 Genetics & Heredity
39/124 Medicine, Research & Experimental

Editor-in-Chief:
Rafael J Yáñez-Muñoz, UK

*2015 Journal Citation Reports® Science Edition (Thomson Reuters, 2016)


News

Thank you

The success of a journal is determined to a large degree by the quality and dedication of reviewers. Editors and Editorial Board members are recognized for their efforts, but the invaluable input of voluntary reviewers is often overlooked. At Gene Therapy, we appreciate that reviewing manuscripts can be demanding and time-consuming, especially with typically overcrowded agendas. With this in mind, we wish to recognize the Gene Therapy reviewers for their efforts. Many thanks to all our reviewers for their support and input! We would also like to reward the top 10 reviewers with a years free online subscription to Nature.
Please see the full list of reviewers.


Open Access Publication

Open

Authors of research articles can opt to pay an article processing charge (APC) for their accepted articles to be open access online immediately upon publication. Open access articles are published under Creative Commons licenses, which allow authors to retain copyright to their work while making it open to readers.
Visit our Open Research Site for detailed information about publishing open access.


Progress and Prospects

Progress and Prospects

Reviews by top researchers in the field. See the recent Progress and Prospects articles.

Special Issues

Special Issues

Essential topics explored in depth in Gene Therapy Special Issues.

News and Commentary

News and Commentary

Have a browse through the latest News and Commentary.
 

Cancer Gene Therapy

Cancer Gene Therapy

Take a look at this month's featured articles from sister title Cancer Gene Therapy.